LV11485A - Nukleinskabe kas kode inhibina alfa vai beta kedes un polipeptidu izmantojot so nukleinskabi sintezes panemiens - Google Patents

Nukleinskabe kas kode inhibina alfa vai beta kedes un polipeptidu izmantojot so nukleinskabi sintezes panemiens

Info

Publication number
LV11485A
LV11485A LV960083A LV960083A LV11485A LV 11485 A LV11485 A LV 11485A LV 960083 A LV960083 A LV 960083A LV 960083 A LV960083 A LV 960083A LV 11485 A LV11485 A LV 11485A
Authority
LV
Latvia
Prior art keywords
nucleic acid
beta
panchem
codode
shingle
Prior art date
Application number
LV960083A
Other languages
English (en)
Other versions
LV11485B (en
Inventor
Anthony John Mason
Peter Horst Seeburg
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419805&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV11485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/906,729 external-priority patent/US4798885A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of LV11485A publication Critical patent/LV11485A/lv
Publication of LV11485B publication Critical patent/LV11485B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-96-83A 1985-10-03 1996-03-14 Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid LV11485B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78391085A 1985-10-03 1985-10-03
US82771086A 1986-02-07 1986-02-07
US06/906,729 US4798885A (en) 1986-02-07 1986-09-12 Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain

Publications (2)

Publication Number Publication Date
LV11485A true LV11485A (lv) 1996-08-20
LV11485B LV11485B (en) 1996-12-20

Family

ID=27419805

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-83A LV11485B (en) 1985-10-03 1996-03-14 Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Country Status (11)

Country Link
EP (1) EP0222491B2 (lv)
AT (1) ATE119937T1 (lv)
AU (3) AU603775B2 (lv)
CA (1) CA1341631C (lv)
DE (1) DE3650267T3 (lv)
ES (1) ES2072248T5 (lv)
HK (1) HK1007332A1 (lv)
IE (1) IE65795B1 (lv)
IL (1) IL80218A (lv)
LV (1) LV11485B (lv)
NZ (2) NZ231899A (lv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218717B1 (en) * 1985-04-18 1998-07-15 Biotechnology Australia Pty. Ltd. Recombinant inhibin
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ219609A (en) * 1986-03-13 1990-09-26 Univ Monash Assay methods for inhibin
CA1302651C (en) * 1986-04-04 1992-06-02 Wylie Walker Vale, Jr. Fsh-releasing peptide
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
US5015729A (en) * 1986-06-24 1991-05-14 The Salk Institute For Biological Studies Ovine inhibin
WO1989011862A1 (en) * 1988-05-31 1989-12-14 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
EP0515494A1 (en) * 1990-02-15 1992-12-02 Chiron Corporation Use of inhibitor of cytokine activity
IL99867A0 (en) * 1991-10-27 1992-08-18 Yissum Res Dev Co Pharmaceutical compositions containing activin a
WO1993009229A1 (en) 1991-11-04 1993-05-13 Genetics Institute, Inc. Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US7025959B1 (en) 1992-02-12 2006-04-11 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh MP121, a growth/differentiation factor of the TGF-β family
US6171584B1 (en) 1992-02-12 2001-01-09 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Method of treatment with growth/differentiation factors of the TGF-β family
US7067637B1 (en) 1992-02-12 2006-06-27 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Antibody or antibody fragments specific for a protein of the TGF-β family
US5807713A (en) * 1992-02-12 1998-09-15 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung DNA encoding growth/differentiation factor
US6120760A (en) 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
EP1378572B1 (en) * 1993-05-12 2006-10-25 Genetics Institute, LLC Bmp-11 compositions
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
IL114397A0 (en) * 1994-07-01 1995-10-31 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF-beta-family
AU779576B2 (en) 1999-02-25 2005-01-27 Auckland Uniservices Limited Diagnosis and therapy of premature ovarian failure
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
AUPR638101A0 (en) 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
ES2282904T3 (es) 2003-09-12 2007-10-16 Wyeth Barras solidas de fosfato calcico inyectables para el suministro de proteinas osteogenicas.
EP1740609A2 (en) 2004-04-27 2007-01-10 Research Development Foundation Antagonism of tgf-beta superfamily receptor signaling
TWI438207B (zh) * 2007-02-21 2014-05-21 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN108285903B (zh) * 2018-01-29 2021-03-12 国家卫生计生委科学技术研究所 一种特异性刺激抗原的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
EP0218717B1 (en) * 1985-04-18 1998-07-15 Biotechnology Australia Pty. Ltd. Recombinant inhibin
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
AU5903986A (en) * 1985-04-18 1986-11-05 Biotechnology Australia Proprietary Limited Recombinant inhibin

Also Published As

Publication number Publication date
DE3650267D1 (de) 1995-04-20
EP0222491A1 (en) 1987-05-20
NZ217727A (en) 1990-05-28
IL80218A (en) 1994-11-28
AU6351286A (en) 1987-04-09
IE65795B1 (en) 1995-11-15
HK1007332A1 (en) 1999-04-09
NZ231899A (en) 1991-07-26
EP0222491B1 (en) 1995-03-15
IE862618L (en) 1987-04-03
ES2072248T5 (es) 2004-05-01
AU603775B2 (en) 1990-11-29
CA1341631C (en) 2012-06-12
AU5243393A (en) 1994-03-10
LV11485B (en) 1996-12-20
AU5465190A (en) 1990-11-29
EP0222491B2 (en) 2003-08-13
DE3650267T3 (de) 2004-05-13
ES2072248T3 (es) 1995-07-16
DE3650267T2 (de) 1995-10-05
ATE119937T1 (de) 1995-04-15

Similar Documents

Publication Publication Date Title
LV11485A (lv) Nukleinskabe kas kode inhibina alfa vai beta kedes un polipeptidu izmantojot so nukleinskabi sintezes panemiens
DK0506825T3 (da) Rekombinante ekspressionsvektorer og oprensningsfremgangsmåder til Thermus thermophilus-DNA-polymerase
DE3683460D1 (de) Nukleinsaeurensonde zur geschlechtsbestimmung vor der geburt.
IT8721107A0 (it) Dell'anidride carbonica. reattore fotobiologico con sistema perfezionato di alimentazione
MW5287A1 (en) Determination of clinical para meters by enzyme immuno process
ATE91722T1 (de) Pferde-gamma-interferon.
EP0272928A3 (en) Compositions and methods for the synthesis and assay of enkephalinase
KR880701876A (ko) 산소농도 측정용 프로브
IT1114740B (it) Procedimento e composizione per il controllo e la pulitura di spillature di acidi
DE3667061D1 (en) New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
ES2033763T3 (es) Metodo para la medicion selectiva de aminoacidos.
DK473985A (da) Toerre enzympraeparater indeholdende d-aminosyreoxidase
PT82225B (pt) Reactores biocataliticos para biocatalizadores imobilizados do tipo gel e outros
IT1164706B (it) Procedimento e composizione di colorazione e di analisi per la determinazione di batteri in fluidi
DK165009C (da) Saccharose-1,6,6'-tricarboxylsyre og salte deraf, fremgangsmaade til fremstilling deraf samt saccharose-1,6,6'-tricarboxylsyres anvendelse i vaskemidler
DK533185A (da) Rhodium-katalysator og anvendelse deraf
JPS5567655A (en) Determination of aromatic amino acid or aminosulfonic acid
KR860007258A (ko) 이미다조[4,5-c]피리딘의 제조방법
IT8453353V0 (it) Fissaggio gancio traino di tipo estraibile manualmente
ES529768A0 (es) Procedimiento para la obtencion de la sal de lisina del acido ((1-(fenilmetil)-1h-indazol-3-il)oxi) acetico dihidrato
IT1163897B (it) Spinotto provvisto di alette elastiche il cui profilo,circa emicircolare o emilindrico,e' adatto al collegamento elettrico spinotto-presa
MN170A6 (en) Triethanolamine salt of orthocresoxyacetic acid as biological stimulant
IT8567424A0 (it) Procedimento per preparare acido 51 carbossietil 2 feniltiofenilaceti co
IT1040534B (it) Acido 0,2, 3 xilidino fenossiace tico e procedimento per la sua preparazione
DK554382A (da) 1,4-tiazankaboxylsyrederivater, deres fremstilling og anvendelse og praeparater hvori disse derivater er til stede